After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Index levels reveal trends and potential turns in markets. This quick overview shows what index level tells you and how to apply it to decisions.
23,042 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
A historic clash over openness in software mirrors today’s AI debate, with investors watching who controls code, data...
A Minnesota food vendor case highlights risks in federal child nutrition programs. Learn how the scheme worked, who’s...
JEPQ offers monthly income via a covered-call strategy, but five-year performance trails uncapped NASDAQ exposure. Th...
Goldman Sachs updated its governance policy to remove formal DEI criteria from director selection, aligning with peer...
In 2026, SoFi's private student loans and refinancing options face a competitive market and shifting rates. This sofi...
XRP is slipping again as macro risk-off tones and a large pool of underwater holders keep a lid on rallies. Analysts ...
AT&T's AI-driven customer app sparked a notable move in the stock market today, march, as investors weigh tech-enable...
Broadcom stands at a pivotal crossroads as AI spending shifts from pilots to production. This article lays out the ke...
A 67-year-old with million 401K confronts looming RMDs that could produce a six-figure federal tax bill. Experts say ...
A newly clarified rule lets unused 529 college-savings money roll into a Roth IRA, potentially producing substantial,...
As storms loom and costs climb, homeowners need more than a mortgage. This report examines resilience financing, insu...